Authors:
Spielmann, M
Llombart-Cussac, A
Kalla, S
Espie, M
Namer, M
Ferrero, JM
Dieras, V
Fumoleau, P
Cuvier, C
Perrocheau, G
Ponzio, A
Kayitalire, L
Pouillart, P
Citation: M. Spielmann et al., Single-agent gemcitabine is active in previously treated metastatic breastcancer, ONCOL-BASEL, 60(4), 2001, pp. 303-307
Authors:
Faivre, S
Kalla, S
Cvitkovic, E
Bourdon, O
Hauteville, D
Dourte, LM
Bensmaine, MA
Itzhaki, M
Marty, M
Extra, JM
Citation: S. Faivre et al., Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experience, ANN ONCOL, 10(9), 1999, pp. 1125-1128
Authors:
Misset, JL
Dieras, V
Gruia, G
Bourgeois, H
Cvitkovic, E
Kalla, S
Bozec, L
Beuzeboc, P
Jasmin, C
Aussel, JP
Riva, A
Azli, N
Pouillart, P
Citation: Jl. Misset et al., Dose-finding study of docetaxel and doxorubicin in first-line treatment ofpatients with metastatic breast cancer, ANN ONCOL, 10(5), 1999, pp. 553-560
Authors:
Wasserman, E
Cuvier, C
Lokiec, F
Goldwasser, F
Kalla, S
Mery-Mignard, D
Ouldkaci, M
Besmaine, A
Dupont-Andre, G
Mahjoubi, M
Marty, M
Misset, JL
Cvitkovic, E
Citation: E. Wasserman et al., Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: Results of two independent phase I studies with pharmacokinetics, J CL ONCOL, 17(6), 1999, pp. 1751-1759
Citation: I. Ali et S. Kalla, A generalized Hankel transform and its use for solving certain partial differential equations, J AUS MAT B, 41, 1999, pp. 105-117